Autologous Transplantation in First Remission in the Rituximab Era in Patients with Mantle Cell Lymphoma: Experience from the Royal Marsden Hospital

被引：0
|
作者：
Mir, Farheen [1 ]
Robinson, Anna [1 ]
Ethell, Mark Edward [1 ]
Potter, Michael [1 ]
Nicholson, Emma [2 ]
Anthias, Chloe [1 ]
Easdale, Sandra [1 ]
Gonzalez-Arias, Carlos [1 ]
Sud, Amit [1 ]
Dearden, Claire E. [3 ]
Chau, Ian [4 ]
Cunningham, David [5 ]
El-Sharkawi, Dima [2 ]
Sharma, Bhupinder [4 ]
Iyengar, Sunil [6 ]
机构：
[1] Royal Marsden Hosp, Sutton, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[3] Royal Marsden Hosp, Dept Haematooncol, Sutton, Surrey, England
[4] Royal Marsden NHS Fdn Trust, London, England
[5] Royal Marsden Hosp, NHS Fdn Trust, London, England
[6] Royal Marsden NHS Fdn Trust, Dept Haematol, London, England
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-166198
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
623
引用
收藏
页码：9366 / 9367
页数：2
相关论文
共 50 条
  • [41] Maintenance Rituximab after High-Dose Therapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
    Roider, Tobias
    Dietrich, Sascha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (11) : 1811 - 1812
  • [42] Autologous stem cell transplantation and Rituximab independently prolong response duration in advanced stage mantle cell lymphoma
    Hoster, E.
    Metzner, B.
    Pfreundschuh, M.
    Truemper, L.
    Hallek, M.
    Woermann, B.
    Duehrsen, U.
    Gisselbracht, C.
    Kluin-Nelemans, J. C.
    Van Hoof, A.
    Unterhalt, M.
    Hiddemann, W.
    Dreyling, M.
    ONKOLOGIE, 2010, 33 : 202 - 202
  • [43] Rituximab improves the outcome of upfront autologous stem cell transplantation in mantle cell lymphoma: A comparison of different strategies
    Rieger, Michael
    Witzens-Harig, Mathias
    Hensel, Manfred
    Seyfarth, Baerbel
    Nickelsen, Maike
    Kneba, Michael
    Schmitz, Norbert
    Ho, Anthony D.
    Dreger, Peter
    BLOOD, 2007, 110 (11) : 358B - 358B
  • [44] Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma
    Dietrich, S.
    Weidle, J.
    Rieger, M.
    Meissner, J.
    Radujkovic, A.
    Ho, A. D.
    Dreger, P.
    Witzens-Harig, M.
    LEUKEMIA, 2014, 28 (03) : 708 - 709
  • [45] Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma
    S Dietrich
    J Weidle
    M Rieger
    J Meissner
    A Radujkovic
    A D Ho
    P Dreger
    M Witzens-Harig
    Leukemia, 2014, 28 : 708 - 709
  • [46] Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma
    Till, Brian G.
    Gooley, Theodore A.
    Crawford, Nathan
    Gopal, Ajay K.
    Maloney, David G.
    Petersdorf, Stephen H.
    Pagel, John M.
    Holmberg, Leona
    Bensinger, William
    Press, Oliver W.
    LEUKEMIA & LYMPHOMA, 2008, 49 (06) : 1062 - 1073
  • [47] Autologous stem cell transplantation in first remission significantly prolongs progression-free and overall survival in mantle-cell lymphoma (MCL)
    Dreyling, M.
    Zoellner, A. -K.
    Stilgenbauer, S.
    Huebel, K.
    Thieblemont, C.
    Metzner, B.
    Kluin-Nelemans, H.
    Hiddemann, W.
    Unterhalt, M.
    Hoster, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 186 - 186
  • [48] Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma
    Umberto Falcone
    Haiyan Jiang
    Shaheena Bashir
    Richard Tsang
    Vishal Kukreti
    Armand Keating
    Michael Crump
    John Kuruvilla
    Bone Marrow Transplantation, 2018, 53 : 347 - 351
  • [49] Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era
    Mathys, Anina
    Bacher, Ulrike
    Banz, Yara
    Legros, Myriam
    Mansouri Taleghani, Behrouz
    Novak, Urban
    Pabst, Thomas
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (02) : 292 - 296
  • [50] Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
    Cowan, Andrew J.
    Stevenson, Philip A.
    Cassaday, Ryan D.
    Graf, Solomon A.
    Fromm, Jonathan R.
    Wu, David
    Holmberg, Leona A.
    Till, Brian G.
    Chauncey, Thomas R.
    Smith, Stephen D.
    Philip, Mary
    Orozco, Johnnie J.
    Shustov, Andrei R.
    Green, Damian J.
    Libby, Edward N., III
    Bensinger, William I.
    Shadman, Mazyar
    Maloney, David G.
    Press, Oliver W.
    Gopal, Ajay K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (02) : 380 - 385
12345